Javier San Martin

Javier San Martin

Former Chief Medical OfficeratArrowhead Pharmaceuticals· In proxies 2021–2024

Pay in FY2024+12% from the year before · Arrowhead Pharmaceuticals stock -27.9% the same year

Javier San Martin was paid $3.5M in FY2024 (Sep), up 12%. Arrowhead Pharmaceuticals stock fell 27.9% that year.

Pay$100 in the stock at the end of FY20 → $45
Pay is from the Summary Compensation Table of each Arrowhead Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Arrowhead PharmaceuticalsPublic company · 5 yr
    • Former Chief Medical Officer2021 – Present · 5 yrStock in role +35%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?